| Disease | Micro RNA | Tissue/ Cell line | MicroRNA regulation | Pathway | More Details | References |
|---|---|---|---|---|---|---|
| Hodgkin lymphoma | hsa-miR-17 | Hodgkin Reed Sternberg cells | Up | p53 signaling pathway | Overexpression of hsa-miR-17 is associated with dysfunctional p53 signaling pathway and also to malignant phenotype in Hodgkin lymphoma. | Gibcus et al., 2011 |
| Hodgkin lymphoma | hsa-miR-106b | Hodgkin Reed Sternberg cells | Up | p53 signaling pathway | Overexpression of hsa-miR-106b is associated with dysfunctional p53 signaling pathway and also to malignant phenotype in Hodgkin lymphoma. | Gibcus et al., 2011 |
| Hepatocellular carcinoma | hsa-miR-93 | Hepatocyte | Up | PI3K-Akt signaling pathway | hsa-miR-93 suppresses the expression of CDKN1A, thereby regulating hepatocellular carcinoma cell apoptosis and c-Met/PI3K-Akt signaling pathway activity. | Ohta et al., 2015 |